Boundless Bio
BOLD
44 hedge funds and large institutions have $9.88M invested in Boundless Bio in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 21 closing their positions.
19% less funds holding
Funds holding: 54 → 44 (-10)
32.38% less ownership
Funds ownership: 76.11% → 43.72% (-32%)
48% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 21
63% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 19
98% less capital invested
Capital invested by funds: $419M → $9.88M (-$409M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$284K |
| 2 |
RC
RBF Capital
San Francisco,
California
|
+$266K |
| 3 |
Renaissance Technologies
New York
|
+$142K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$141K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$73.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$399M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.29M |
| 3 |
BlackRock
New York
|
-$749K |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$378K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$363K |
BOLD Hedge Fund Activity: Q2 2025 in Review
44 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Boundless Bio (BOLD) for Q2 2025, worth a combined $9.88M — down 98% from $419M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of BOLD and 11 opened new positions — a net loss of 10 holders — while 19 trimmed existing stakes and 7 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $284K. The largest seller was Nuveen, exiting entirely with an estimated $399M sold.
- 44 institutional investors held Boundless Bio (BOLD) as of Q2 2025, down from 54 in Q1 2025.
- Funds reported $9.88M of Boundless Bio stock for Q2 2025, down 98% quarter-over-quarter.
- 11 funds opened new Boundless Bio positions in Q2 2025 and 21 closed out, a net change of -10 holders.
- The largest Boundless Bio buyer in Q2 2025 was Millennium Management, an estimated $284K added.
- The largest Boundless Bio seller in Q2 2025 was Nuveen, an estimated $399M sold.
Based on aggregated 13F filings for Q2 2025.